TEVA241213P16500
- 0.13
- +0.01+8.33%
Teva Pharmaceutical Industries Newsroom
10 Health Care Stocks Whale Activity In Today's Session
Teva Announces New Patient Access Program With Direct Relief to Provide Access to Inhalers for Uninsured Patients
Medincell Publishes Its Consolidated Half-year Financial Results
Press Release: Medincell Publishes Its Consolidated Half-year Financial Results
Unusual Options Activity: PFE, HSY and Others Attract Market Bets, PFE V/OI Ratio Reaches 167.1
EST Dec 6th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Express News | Takeda Pharmaceutical: selling 49% of the shares in the joint venture with Teva Pharmaceutical Industries, receiving 55 billion yen.
Takeda Pharmaceutical: To Receive Y55B From Sale of 49% Stake in JV With Teva Pharmaceutical Industries
Express News | Teva Pharmaceutical Industries of Israel will sell its joint venture business in Japan with Takeda Pharmaceutical to JKI, with the transaction expected to be completed by April 2025.
Teva Entered Into An Agreement With JKI Co. Established By The Fund Managed And Operated By Private Equity Firm J-Will Partners Co., Through Which JKI Will Acquire Teva-Takeda; The Agreement Is Aligned With Teva's Pivot To Growth Strategy To Focus Its...
Teva Pharmaceuticals to Sell Japan Venture Teva-Takeda to JKI Co.
Teva Announces Agreement to Divest Teva-Takeda, Its Business Venture in Japan
Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23
Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients
Teva Shares Phase 3 SPACE Trial Results Highlighting The Efficacy And Safety Of AJOVY (Fremanezumab) In Preventing Episodic Migraine In Children And Adolescents
Teva Pharmaceutical Industries Options Spot-On: On November 29th, 141.86K Contracts Were Traded, With 674.74K Open Interest
On November 29th ET, $Teva Pharmaceutical Industries(TEVA.US)$ had active options trading, with a total trading volume of 141.86K options for the day, of which put options accounted for 6.54% of the
Unusual Options Activity: AMZN, TEVA and Others Attract Market Bets, AMZN V/OI Ratio Reaches 859.4
EST Nov 29th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Unusual Options Activity: TEVA, IONQ and Others Attract Market Bets, TEVA V/OI Ratio Reaches 253.5
EST Nov 29th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Press Release: Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 10th, 2024
Unusual Options Activity: AAL, COIN and Others Attract Market Bets, AAL V/OI Ratio Reaches 75.0
EST Nov 27th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference